Obsidian CMO reports stock option holdings
Obsidian Therapeutics, Inc. reports the initial equity holdings of Chief Medical Officer Hari Parameswaran.
Rhea-AI Filing Summary
Obsidian Therapeutics, Inc. reports the initial equity holdings of Chief Medical Officer Hari Parameswaran. The filing lists several stock options (right to buy) over Common Stock with an exercise price of $0.7800 per share and expirations on February 27, 2033 and June 24, 2034. One option covering 1,770,369 underlying shares began vesting with 25% exercisable on January 17, 2024, with the balance vesting in twelve equal quarterly installments, subject to continued service. Additional options over 48,685 and 97,370 underlying shares are fully vested and exercisable. A further option for 943,500 underlying shares vests in sixteen equal monthly installments following June 25, 2024, also conditioned on continued service. No purchases or sales are reported; this statement records existing option positions.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Hari Parameswaran
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 3,005,979 contracts (Direct)
Footnotes (3)
- F1. 25% of the shares underlying this option vested and became exercisable on January 17, 2024, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- F2. The shares underlying this option are fully vested and exercisable.
- F3. The shares underlying this option shall vest in sixteen (16) equal monthly installments following June 25, 2024, subject to the Reporting Person's continued service on each such vesting date.
Key Figures
Largest option underlying shares: 1770369.0000 shares
Fully vested option block 1: 48685.0000 shares
Fully vested option block 2: 97370.0000 shares
+4 more
7 metrics
Largest option underlying shares
1770369.0000 shares
Option over Common Stock with 25% vested on January 17, 2024 and remainder in 12 quarterly installments
Fully vested option block 1
48685.0000 shares
Underlying Common Stock; footnote states shares are fully vested and exercisable
Fully vested option block 2
97370.0000 shares
Underlying Common Stock; fully vested and exercisable per footnote
New monthly vesting option
943500.0000 shares
Underlying Common Stock; vests in 16 equal monthly installments following June 25, 2024
Option exercise price
$0.7800 per share
Exercise price for all reported Stock Option (Right to Buy) positions
First option expiration
February 27, 2033
Expiration date for several stock option positions
Second option expiration
June 24, 2034
Expiration date for the 943500.0000-share option position
Key Terms
Stock Option (Right to Buy), exercise price, vested and exercisable, quarterly installments, +1 more
5 terms
Stock Option (Right to Buy) financial
"The security title is listed as Stock Option (Right to Buy) over Common Stock"
exercise price financial
"The options have an exercise price of 0.7800 per share of Common Stock"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vested and exercisable financial
"The shares underlying this option are fully vested and exercisable"
quarterly installments financial
"The remainder vesting in twelve equal quarterly installments thereafter"
monthly installments financial
"This option shall vest in sixteen equal monthly installments following June 25, 2024"
Monthly installments are regular, fixed payments made each month to gradually pay off a larger amount, such as a loan or purchase. Think of it like paying for a big item in small, manageable parts instead of all at once. For investors, understanding installment payments helps gauge how debts are structured and how they might affect financial stability or cash flow over time.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Obsidian Therapeutics (OBX) disclose in this Form 3?
The Form 3 discloses initial stock option holdings of Chief Medical Officer Hari Parameswaran, detailing multiple option grants, exercise price of $0.7800, expiration dates in 2033 and 2034, and specific vesting schedules.
What is the exercise price of the stock options reported for OBX’s CMO?
All reported stock options have an exercise price of $0.7800 per share. These options relate to Obsidian Therapeutics Common Stock and carry varying vesting schedules and expirations in 2033 and 2034, as specified in the filing.
Are any of Hari Parameswaran’s Obsidian (OBX) options already fully vested?
Yes. The filing states that the shares underlying certain options, including blocks of 48,685 and 97,370 underlying shares, are fully vested and exercisable, providing immediate exercise rights at $0.7800 per share.
Does this OBX Form 3 show any stock purchases or sales by the CMO?
No. The Form 3 reports holdings of stock options only and shows no buy or sell transactions. It establishes Hari Parameswaran’s derivative ownership position in Obsidian Therapeutics at the time of becoming a reporting person.
AI-generated analysis. How Rhea-AI works. Not financial advice.
